NCT05867771View on ClinicalTrials.gov

A Study of PM1022 in Patients With Advanced Tumors

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

April 10, 2024

Study Completion Date

April 10, 2025

Conditions
Advanced Tumors
Interventions
DRUG

PM1022

PM1022 Injection

Trial Locations (2)

Unknown

RECRUITING

Yan Zhang, Jinan

RECRUITING

Ye Guo, Shanghai

Sponsors

Lead Sponsor

Biotheus Inc.
All Listed Sponsors
lead

Biotheus Inc.

INDUSTRY

NCT05867771 - A Study of PM1022 in Patients With Advanced Tumors | Biotech Hunter | Biotech Hunter